Watershed and Evogene Receive Grant to Advance CRISPR Tech for Crustaceans, Targeting Sustainable Aquaculture
Portfolio Pulse from Benzinga Newsdesk
Watershed AC and Evogene Ltd. have received a grant to advance CRISPR technology for crustaceans, aiming to improve traits like growth rate and disease resistance. This collaboration targets sustainable aquaculture, focusing on giant freshwater prawn, white leg shrimp, and red swamp crayfish.
October 08, 2024 | 11:11 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evogene Ltd. has received a grant to further develop CRISPR technology for crustaceans, which could enhance sustainable aquaculture. This development may positively impact Evogene's market position in the life-science sector.
The grant allows Evogene to continue its CRISPR development, which aligns with the growing aquaculture market. Successful application of this technology could enhance Evogene's reputation and market share in sustainable biotech solutions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80